AXA S.A. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
AXA S.A. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,310,051
+5.5%
60,304
-0.4%
0.03%
+13.0%
Q2 2023$6,930,521
-15.8%
60,518
+1.4%
0.02%
-17.9%
Q1 2023$8,226,384
-34.9%
59,685
-38.8%
0.03%
-39.1%
Q4 2022$12,643,639
-41.7%
97,574
-50.3%
0.05%
+7.0%
Q3 2022$21,689,527
+48.1%
196,210
+0.4%
0.04%
+59.3%
Q2 2022$14,645,992
-5.9%
195,384
-1.9%
0.03%
+22.7%
Q1 2022$15,560,440
+73.5%
199,192
+100.0%
0.02%
-4.3%
Q4 2021$8,969,000
-1.5%
99,597
+1.2%
0.02%
-11.5%
Q3 2021$9,101,000
-38.2%
98,407
-48.1%
0.03%
+23.8%
Q2 2021$14,738,000
+93.9%
189,580
+85.9%
0.02%
-8.7%
Q1 2021$7,601,000
-38.0%
101,989
+41.9%
0.02%
-39.5%
Q4 2020$12,255,000
+26.5%
71,882
+4.2%
0.04%
+8.6%
Q3 2020$9,688,000
-59.7%
68,985
-54.0%
0.04%
-25.5%
Q2 2020$24,048,000
+84.4%
149,980
+12.5%
0.05%
+42.4%
Q1 2020$13,044,000
-19.7%
133,342
+5.9%
0.03%0.0%
Q4 2019$16,248,000
+75.4%
125,912
+2.4%
0.03%
+83.3%
Q3 2019$9,262,000
-50.5%
122,972
-0.2%
0.02%
-51.4%
Q2 2019$18,716,000
+90.7%
123,170
+49.5%
0.04%
-2.6%
Q1 2019$9,816,000
+3.4%
82,361
-5.3%
0.04%
-7.3%
Q4 2018$9,490,000
-32.5%
86,961
-0.1%
0.04%
-21.2%
Q3 2018$14,061,000
+22.1%
87,061
-0.1%
0.05%
+18.2%
Q2 2018$11,514,000
+160.8%
87,107
+46.2%
0.04%
+144.4%
Q1 2018$4,415,000
+261.6%
59,593
-29.4%
0.02%
+260.0%
Q4 2014$1,221,00084,4000.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders